Sun, G., Mei, H., Wang, A., Pan, T., Zhou, Y., Chen, G., Zeng, J., Bian, K., Davidson-Moncada, J., Pei, B., Han, L., Ren, J., Zhu, X. (2025). CTA311, a universal anti-CD19 CAR t-cell therapy with improved persistence for patients with CD19+ relapsed/ refractory (R/R) b-cell acute lymphoblastic leukemia (B-ALL). Blood. https://doi.org/10.1182/blood-2025-5920